Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지

A Fifteen-year Epidemiological Study of Ventriculoperitoneal Shunt Infections in Pediatric Patients: A Single Center Experience

소아 환자에서의 뇌실-복강 단락 감염의 역학적 고찰: 15년 간의 단일 기관 연구

  • Kim, Yeon Kyung (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Shin, Hyung Jin (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Yae Jean (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 김연경 (성균관대학교 의과대학 삼성서울병원 소아청소년과학교실) ;
  • 신형진 (성균관대학교 의과대학 삼성서울병원 신경외과학교실) ;
  • 김예진 (성균관대학교 의과대학 삼성서울병원 소아청소년과학교실)
  • Received : 2012.10.12
  • Accepted : 2012.10.24
  • Published : 2012.12.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Ventriculoperitoneal (VP) shunt insertion is an important treatment modality in children with hydrocephalus. VP shunt infection is a major complication and an important factor that determines the surgery outcome. This 15-year study was performed to evaluate the epidemiology of VP shunt infections in pediatric patients treated at our center. Methods : A retrospective review of medical records was performed in patients 18 years old or younger who underwent VP shunt insertion surgery from April 1995 to June 2010. Results : Three hundred twenty-seven VP shunt surgeries were performed in a total of 190 pediatric patients (83 females, 107 males). The median age of the patients was 2.4 years (range, 0.02-17.9 years). Having a malignant brain tumor was the most frequent cause for VP shunt insertion. The shunt infection rate was 6.7% (22/327) per 100 operations and 9.5% (18/190) per 100 patients, and the incidence rate was 0.45 infection cases per 100 shunt operations-year. The most common pathogen was coagulase-negative staphylococcus (n=7) followed by methicillin resistant Staphylococcus aureus (n=1). Ten cases were treated with vancomycin and beta-lactam antibiotic (cephalosporin or carbapenem) combination therapy and 7 cases were treated with vancomycin monotherapy. The median duration of antibiotic treatment was 26 days (range, 7 to 58 days). Surgical intervention was performed in 18 cases (18/22, 81.8%). Conclusion : Epidemiologic information regarding VP shunt infections in pediatric patients is valuable that will help guide proper antibiotic management. Additional studies on the risk factors for developing VP shunt infections are also warranted.

목 적 : 뇌실-복강 단락 수술은 수두증이 있는 소아 환자에서 중요한 치료 방법 중 하나이다. 뇌실-복강 단락에서 단락 감염은 중요한 합병증이며 수술의 예후를 결정하는 중요한 요인이다. 이 연구는 소아 환자에서의 뇌실-복강 단락 감염의 역학적 특성과 임상 증상, 치료와 예후를 파악하고 진단 및 치료에 도움이 되고자 하였다. 방 법 : 1995년 4월부터 2010년 6월까지 뇌실-복강 단락 수술을 시행 받은 18세 이하의 환자를 대상으로 하였으며 후향적으로 의무 기록을 분석하였다. 결 과 : 총 190명(여자 82명, 남자 107명)의 환자에서 327건의 뇌실-복강 단락 수술을 시행하였다. 중위 연령은 2.4세이며(0.02-17.9세) 뇌실-복강 단락 수술의 가장 흔한 원인은 악성 뇌종양이었다. 수술 1건 당 감염률은 6.7% (22/327건), 환자 1명 당 감염률은 9.5% (18/190명)이며 100건의 수술-년 당 감염은 0.45건 이었다. 가장 흔한 원인 균은 coagulase-negative staphylococcus (7건) 이며 methicillin resistant Staphylococcus aureus에 의한 감염은 1건 이었다. 10건의 감염에서 vancomycin과 beta-lactam antibiotics (cephalosporin or carbapenem)의 복합 정주 치료를 시행하였으며 7건의 감염에서 vancomycin 단독 정주 치료를 시행하였다. 치료 기간의 중앙값은 26일(7-58일)이었으며 수술적 치료는 18건에서 시행하였다(18/22건, 81.8%). 결 론 : 본 연구는 단일 기관에서 15년 동안의 뇌실-복강 단락 감염의 역학을 요약한 연구로 소아 환자에서의 뇌실-복강 단락 감염의 역학적 정보는 적절한 치료를 시행하는데 큰 도움이 될 것이다. 향후 단락 감염의 발생과 관련한 위험 인자에 대한 추가적인 연구가 필요할 것으로 사료된다.

Keywords

References

  1. Di Rocco C, Massimi L, Tamburrini G. Shunts vs endoscopic third ventriculostomy in infants: are there different types and/or rates of complications? A review. Childs Nerv Syst 2006;22:1573-89. https://doi.org/10.1007/s00381-006-0194-4
  2. Owen R, Pittman T. Delayed external ventriculoperitoneal shunt infection. J Ky Med Assoc 2004;102:349-52.
  3. Chadduck W, Adametz J. Incidence of seizures in patients with myelomeningocele: a multifactorial analysis. Surg Neurol 1988;30:281-5. https://doi.org/10.1016/0090-3019(88)90300-X
  4. Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP. Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 1984;60:1014-21. https://doi.org/10.3171/jns.1984.60.5.1014
  5. Prusseit J, Simon M, von der Brelie C, Heep A, Molitor E, Volz S, et al. Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children. Pediatr Neurosurg 2009;45:325-36. https://doi.org/10.1159/000257520
  6. Anderson EJ, Yogev R. A rational approach to the management of ventricular shunt infections. Pediatr Infect Dis J 2005;24:557-8. https://doi.org/10.1097/01.inf.0000165307.29619.82
  7. Choux M, Genitori L, Lang D, Lena G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992;77:875-80. https://doi.org/10.3171/jns.1992.77.6.0875
  8. Key CB, Rothrock SG, Falk JL. Cerebrospinal fluid shunt complications: an emergency medicine perspective. Pediatr Emerg Care 1995;11:265-73. https://doi.org/10.1097/00006565-199510000-00001
  9. Rowin ME, Patel VV, Christenson JC. Pediatric intensive care unit nosocomial infections: epidemiology, sources and solutions. Crit Care Clin 2003;19:473-87. https://doi.org/10.1016/S0749-0704(03)00009-5
  10. Conen A, Walti LN, Merlo A, Fluckiger U, Battegay M, Trampuz A. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Clin Infect Dis 2008;47:73-82. https://doi.org/10.1086/588298
  11. James HE, Walsh JW, Wilson HD, Connor JD. The management of cerebrospinal fluid shunt infections: a clinical experience. Acta Neurochir (Wien) 1981;59:157-66. https://doi.org/10.1007/BF01406345
  12. James HE, Walsh JW, Wilson HD, Connor JD, Bean JR, Tibbs PA. Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery 1980;7:459-63. https://doi.org/10.1227/00006123-198011000-00006
  13. Schreffler RT, Schreffler AJ, Wittler RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 2002;21:632-6. https://doi.org/10.1097/00006454-200207000-00006
  14. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39: 1267-84. https://doi.org/10.1086/425368
  15. Whitehead WE, Kestle JR. The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg 2001;35:205-10. https://doi.org/10.1159/000050422
  16. McClinton D, Carraccio C, Englander R. Predictors of ventriculoperitoneal shunt pathology. Pediatr Infect Dis J 2001;20:593-7. https://doi.org/10.1097/00006454-200106000-00009
  17. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003;36:858-62. https://doi.org/10.1086/368191
  18. Reddy GK. Ventriculoperitoneal shunt surgery and the incidence of shunt revision in adult patients with hemorrhage-related hydrocephalus. Clin Neurol Neurosurg 2012;114:1211-6. https://doi.org/10.1016/j.clineuro.2012.02.050
  19. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections 1988. Z Arztl Fortbild (Jena) 1991;85:818-27.
  20. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32. https://doi.org/10.1016/j.ajic.2008.03.002
  21. Bokhary MA, Kamal H. Ventriculo-peritoneal shunt infections in infants and children. Libyan J Med 2008;3: 20-2. https://doi.org/10.4176/080104
  22. Baird C, O'Connor D, Pittman T. Late shunt infections. Pediatr Neurosurg 1999;31:269-73. https://doi.org/10.1159/000028874
  23. Braga MH, Carvalho GT, Brand ao RA, Lima FB, Costa BS. Early shunt complications in 46 children with hydrocephalus. Arq Neuropsiquiatr 2009;67:273-7. https://doi.org/10.1590/S0004-282X2009000200019
  24. Enger PO Svendsen F, Sommerfelt K, Wester K. Shunt revisions in children--can they be avoided? Experiences from a population-based study. Pediatr Neurosurg 2005; 41:300-4. https://doi.org/10.1159/000088732
  25. Kontny U, Hofling B, Gutjahr P, Voth D, Schwarz M, Schmitt HJ. CSF shunt infections in children. Infection 1993;21:89-92. https://doi.org/10.1007/BF01710738
  26. Mancao M, Miller C, Cochrane B, Hoff C, Sauter K, Weber E. Cerebrospinal fluid shunt infections in infants and children in Mobile, Alabama. Acta Paediatr 1998; 87:667-70. https://doi.org/10.1111/j.1651-2227.1998.tb01527.x
  27. Odio C, McCracken GH, Jr., Nelson JD. CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child 1984;138:1103-8. https://doi.org/10.1001/archpedi.1984.02140500009004
  28. Stevens NT, Greene CM, O'Gara JP, Bayston R, Sattar MT, Farrell M, et al. Ventriculoperitoneal shunt-related infections caused by Staphylococcus epidermidis: pathogenesis and implications for treatment. Br J Neurosurg 2012;26:792-7. https://doi.org/10.3109/02688697.2011.651514
  29. Olson ME, Slater SR, Rupp ME, Fey PD. Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm. J Antimicrob Chemother 2010;65:2164-71. https://doi.org/10.1093/jac/dkq314
  30. Silva LV, Arauuo MT, Santos KR, Nunes AP. Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus spp strains. Mem Inst Oswaldo Cruz 2011;106: 44-50.
  31. Simon TD, Hall M, Riva-Cambrin J, Albert JE, Jeffries HE, Lafleur B, et al. Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article. J Neurosurg Pediatr 2009;4:156-65. https://doi.org/10.3171/2009.3.PEDS08215
  32. Tuan TJ, Thorell EA, Hamblett NM, Kestle JR, Rosenfeld M, Simon TD. Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 2011;30:731-5. https://doi.org/10.1097/INF.0b013e318218ac0e